Accolade
Buying intent
57 tracked signals | Top 15 topics are below | Engineering and Operations are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Accolade's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
16d ago
17d ago
17d ago
19d ago
12d ago
17d ago
17d ago
12d ago
20d ago
17d ago
29d ago
17d ago
22d ago
19d ago
19d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Accolade
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
16 people across every department at Accolade, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileAccolade is now a part of Transcarent. We are the One Place for Health and Care, bringing medical, pharmacy, and point solutions together with the WayFinding™ experience, the first and only generative AI-powered health and care platform for health consumers. Our WayFinding experience, paired with transparent and consumer-driven pharmacy care, 2nd.MD expert medical opinions, and virtual primary car
New capability sought
Employee posts (LinkedIn)Professional Development; Strategic Alliances
Top accounts researching Accolade
names withheld on the public pageThese are companies whose own people brought up Accolade unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
Accolade's own team shows 9 signals on this topic. No one outside Accolade has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Virtual Assistant801 cos · 5,502 people
- Professional Development37,632 cos · 252,574 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Engineering — 4 people; Leadership — 2 people; Operations — 1 person; HR / Talent — 1 person; IT — 1 person; Security — 1 person
What's been said
public posts by Accolade's teamNo public post naming Accolade has surfaced in the past year, so this is what Accolade's own team is posting about publicly — their topics, in their words.
Happy to run with my son for his first race to support #hopetravels5k #helphopelive
May 2026I’m proud to be part of a movement that’s transforming how people experience health and care. When Transcarent launched the WayFinding™ experience in 2024, we redefined what was possible with AI-powered healthcare navigation, and we haven’t stopped innovating since. By listening closely to our Members and clients, and applying cutting-edge technologies like agentic AI, we’re continuing to push healthcare forward. This is what people really need: an experience that anticipates what’s next and takes action on their behalf to help them move forward with greater confidence and less friction. Just Ask Transcarent. We’ll take it from here.
May 2026We’re building the future of health and care! By expanding the Transcarent WayFinding™ experience to include a partnership with SmithRx, we’re helping Members get the right prescriptions at the right price—without the usual confusion. I’m proud to be part of a team making pharmacy simpler, clearer, and more affordable for everyone. This is what changing the status quo in pharmacy looks like!
May 2026